We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test uses technology that can detect a specific spot where mutation occurs, allowing for precise detection and differentiation of the coronavirus from mutated strains. Read More
The U.S. has joined the World Health Organization (WHO)’s Access to COVID-19 Tools (ACT) Accelerator program, a global effort to speed development and production of coronavirus vaccines, treatments and diagnostic tests, and to help lower-income nations obtain them. Read More
The handheld device directs precise wavelengths of targeted light to the back of the throat and surrounding tissues and is designed for at-home treatment of mild-to-moderate COVID-19 in adult patients. Read More
The coronavirus treatment candidate, which is delivered by a pressurized metered-dose inhaler, has both bronchodilator and anti-inflammatory activities, the company said. Read More
The FDA is currently working with test developers and conducting ongoing data analyses to evaluate all authorized tests, but said it believes there is only a low risk of mutations affecting overall testing accuracy. Read More
ISU’s vaccine is “intended to address some of the limitations of the vaccines currently in development by targeting room temperature storage and single-dose nasal self-administration as key capabilities,” Zeteo said. Read More
In a separate 13-3 vote with two abstentions, the expert panel concluded that the risks of the Neovasc Reducer System outweigh the benefits for specific patients. Read More
RSS
